GlassScriptPhysician profile
Nikil Swamy
NPI 1396186979
$5,857.82
in general payments reported to CMS, 2019-2025
20 companies · $811 in 2025
The $811 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2020: $1,378 · 2021: $1,640 · 2022: $566 · 2023: $357 · 2024: $918 · 2025: $811.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,085.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,085.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,049.30 | 2020-2025 | Red 72, Penumbra System, Penumbra Coil 400 |
| Stryker Corporation | $1,136.09 | 2020-2025 | Trevo, Target, Surpass Evolve |
| Medtronic, INC. | $1,101.96 | 2021-2025 | Pipeline |
| Depuy Synthes Sales INC. | $342.53 | 2021-2024 | Emboguard, Trufill |
| Route 92 Medical, INC. | $220.01 | 2024-2025 | 8f Base Camp Sheath System |
| Medtronic USA, INC. | $188.41 | 2019 | |
| Microvention, INC. | $157.95 | 2020 | |
| Balt USA, LLC | $148.78 | 2021 | |
| Xtant Medical INC | $120.65 | 2024 | |
| Abbvie INC. | $57.25 | 2025 | |
| Angiodynamics, INC. | $51.75 | 2021-2022 | |
| Viz.Ai, INC. | $49.29 | 2022 | |
| Amgen INC. | $49.08 | 2021-2025 | Evenity |
| Ucb, INC. | $45.39 | 2024 | Fintepla |
| Imperative Care, INC | $44.36 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $22.80 | 2023 | Valtoco |
| Lilly USA, LLC | $19.31 | 2023 | Amyvid |
| Sk Life Science, INC. | $19.12 | 2020 | |
| Neurocrine Biosciences, INC. | $18.56 | 2020 | |
| Mallinckrodt Hospital Products INC. | $15.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nikil Swamy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.